Original ResearchImproved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus
Under a Creative Commons license
open access
Keywords
BRAF V600–mutant melanoma
Adjuvant
Pyrexia
BRAF inhibitor
Dabrafenib
MEK inhibitor
Trametinib
Targeted therapy
Cited by (0)
© 2021 The Authors. Published by Elsevier Ltd.